24小时热门版块排行榜    

查看: 791  |  回复: 36
【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 123n 的 34 个金币 ,回帖就立即获得 2 个金币,每人有 1 次机会
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

123n

木虫 (正式写手)


[交流] 美国芝加哥大学Zhou Lab招聘化学,化学生物学,或者抗体/蛋白质工程背景博后

Position Title:        Postdoc in Chemical Biology and Protein/Antibody Engineering


Division/Department: Biological Sciences Division; Department of Radiation and Cellular Oncology; Department of Chemistry

Faculty Sponsor: Jie Zhou, Ph.D.   Assistant Professor


Lab introduction
The Zhou Lab at the University of Chicago is seeking an enthusiastic and dedicated Postdoctoral Researcher with a strong interest in the development of targeted immunotherapies with chemical biology and protein/antibody engineering approaches. We work at the vibrant interface of chemistry and biology, with a specific focus on the complex dynamics of cell surfaces within the tumor microenvironment (TME). This interdisciplinary position presents an excellent opportunity for a Ph.D. graduate seeking to make significant contributions to the field of protein/antibody engineering & immunotherapy. This position offers an opportunity to work in a dynamic, collaborative environment within the Department of Radiation & Cellular Oncology and the Department of Chemistry at the University of Chicago. You'll work closely with Dr. Zhou, who has extensive experience and training in peptide chemistry, chemical biology, protein/antibody/cell engineering, and immunotherapy. The Zhou Lab is also part of the University of Chicago Comprehensive Cancer Center, offering additional opportunities for collaborative research and career development. For more information:
https://voices.uchicago.edu/jzhoulab/research-2/
https://biologicalsciences.uchicago.edu/faculty/jie-zhou
https://chemistry.uchicago.edu/faculty/jie-zhou


Projects and technologies
The successful candidate will be integral to our ongoing research projects, with a focus on:
•        Elucidating new chemical and biological phenomena or mechanisms on cell membranes contributing to pathological phenotypes.
•        Harnessing these insights to drive the development of next-generation immunotherapies.
•        Engineering small molecules and biologics to enhance our understanding of diseases and facilitate the creation of innovative therapeutics.
The potential candidate will employ a diverse range of methodologies/technologies, including synthetic chemistry, proteomics, functional genomics, and protein/antibody/cell engineering. They will also leverage combinatorial selection technologies such as phage/yeast/cell/virus display, coupled with next-generation sequencing (NGS) and bioinformatics, to advance biological research.

Qualification
The selected individual is expected to proficiently manage multiple and competing projects and to maintain comprehensive and clear research notes. The successful candidate should be capable of presenting their research progress in internal group meetings and external scientific seminars to the broader scientific community within and outside the University of Chicago. We are seeking candidates who are highly independent, resourceful, and passionate about pioneering cancer immunotherapies.
A Ph.D. or educational equivalent required Ph.D. in chemistry, chemical biology or biochemistry are preferred.  Organic chemistry background OR experience of molecular biology experiments, such as cloning, protein expression and purification, is appreciated. Knowledge of basic immunological concepts is appreciated. Experience in combinatorial selection technologies, next-generation sequencing (NGS), and bioinformatics is highly desirable. Ability to write and verbalize clear and complete research findings in the English language. Demonstrated ability to work independently and as a team member.

Benefit
Compensation in the Biological Sciences Division follows the NIH NRSA Stipend scale. Additional information on benefits and being a postdoc in the University of Chicago Biological Sciences Division can be found at https://bsdpostdoc.uchicago.edu/. The University of Chicago is an Affirmative Action/Equal Opportunity/Disabled/Veterans Employer


Contact
Motivated candidates should submit a CV with names of 2-3 referees to Dr. Jie Zhou at jiezhou6@uchicago.edu. We look forward to your application and the potential to welcome you to our team.
回复此楼

» 猜你喜欢

» 抢金币啦!回帖就可以得到:

查看全部散金贴

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

poi_lkj

新虫 (初入文坛)



123n(金币+2): 谢谢参与
芝加哥,当心啊兄弟
13楼2023-10-25 13:22:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 37 个回答
简单回复
jiaoxg12楼
2023-10-25 12:06   回复  
123n(金币+2): 谢谢参与
提示: 如果您在30分钟内回复过其他散金贴,则可能无法领取此贴金币
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[硕博家园] 每到中夜,情难自抑 +21 sioc-sunj 2024-05-28 40/2000 2024-05-29 15:52 by sioc-sunj
[教师之家] 中年 +10 459582015 2024-05-28 11/550 2024-05-29 15:50 by 小龙虾2008
[考博] 申博求助?本硕双非一篇三区和四区去985工科非天坑专业有没有希望? +3 LYS1200 2024-05-29 5/250 2024-05-29 14:45 by 未来富婆蛙
[博后之家] 2024公派博后申请 +3 326lhpqk 2024-05-27 4/200 2024-05-29 14:42 by 113745685
[考博] 招聘催化、储能博士 +8 dfjsf 2024-05-24 12/600 2024-05-29 11:23 by one time
[论文投稿] 真急着毕业,CPB主编终审17天了,邮件催稿了两次,就是一点动静没有 5+3 kkkk夏 2024-05-28 6/300 2024-05-29 11:18 by hitsdu
[基金申请] 入职高校3年发表10+SCI,尽人事听天命 +25 kaoyan250 2024-05-27 34/1700 2024-05-29 10:34 by kaoyan250
[论文投稿] 核心初审被拒,理由是“选题的意义不明确,文章写得不像是科技论文”,怎么改 5+3 工藤雷花樱 2024-05-27 8/400 2024-05-29 10:09 by topedit
[有机交流] 液相纯度高,但产品析不太出来 10+4 cui19236 2024-05-27 8/400 2024-05-29 09:09 by chu-yue
[教师之家] 女博士高校择业三天之内签合同,求支招 +40 chengmy19 2024-05-23 57/2850 2024-05-29 07:54 by hhbaust
[基金申请] 如果您是国自然评审专家 +3 丁香园账户 2024-05-28 3/150 2024-05-29 06:44 by gaohui8888
[基金申请] E05青基有几个评审 +4 KYXY123 2024-05-28 4/200 2024-05-28 19:25 by popt2t
[电化学] 如题SEI问题 5+3 ERRORe 2024-05-24 4/200 2024-05-28 10:01 by 姜尚真。
[硕博家园] 每天学术时间不能保证,能保证的只有: +5 hahamyid 2024-05-27 5/250 2024-05-27 18:18 by 沉默如昔
[硕博家园] 课题做到一半担心做不出来怎么办 +4 mkpooooo 2024-05-27 7/350 2024-05-27 11:56 by kanmiaolucky
[硕博家园] 周日 +6 1加油哦棒 2024-05-26 9/450 2024-05-27 10:30 by hahamyid
[基金申请] 化学口面上 +7 乐丰松庆 2024-05-23 17/850 2024-05-27 10:23 by ddr6021023
[基金申请] 转发,”朋友说招呼都定点打到他那里了" +25 babu2015 2024-05-23 30/1500 2024-05-27 05:38 by wangzhenyft
[考博] 24年还有机会申博吗,求博导收留 +3 鄙人康康 2024-05-23 6/300 2024-05-27 00:29 by 鄙人康康
[硕博家园] 研0 +6 控制调剂yl 2024-05-25 11/550 2024-05-26 23:37 by sakuraai
信息提示
请填处理意见